Relief Therapeutics Holding SA (RLFTF)
OTCMKTS · Delayed Price · Currency is USD
2.940
-0.260 (-8.13%)
Aug 5, 2025, 2:57 PM EDT
Accolade Market Cap
RLFTF has a market cap or net worth of $38.44 million as of August 6, 2025. Its market cap has increased by 133.83% in one year.
Market Cap
38.44M
Enterprise Value
22.40M
Revenue
9.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.94
Market Cap Chart
Since July 19, 2016, RLFTF's market cap has decreased from 93.95M to 38.44M, a decrease of -59.08%. That is a compound annual growth rate of -9.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 38.44M | -33.96% |
| Dec 30, 2024 | 58.21M | 96.41% |
| Dec 29, 2023 | 29.64M | -79.23% |
| Dec 30, 2022 | 142.71M | -52.45% |
| Dec 30, 2021 | 300.10M | -69.64% |
| Dec 30, 2020 | 988.40M | 45,169.87% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 19, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |